Lung Cancer Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who are between 18 and 75 years old at the time of joining the trial.
- People who have been diagnosed with non-small cell lung cancer (a common type of lung cancer) confirmed by laboratory testing of tissue or cell samples, at a stage ranging from stage II to stage IV.
- People whose tissue slide images meet the quality requirements and can be reviewed through a specific computer system called KindMED (DeepGEM).
- People whose tumour tissue has been successfully analysed by the DeepGEM artificial intelligence tool to predict changes in specific genes (EGFR, ALK, or ROS1).
- People who have not previously received any systemic cancer treatment, such as chemotherapy, targeted therapy, or immunotherapy.
- People who are willing and able to follow all study requirements, attend follow-up visits, and provide written consent to participate.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who have previously received any systemic cancer treatment, including chemotherapy, radiation therapy, targeted therapy (such as certain antibody or kinase-blocking medicines), before joining the trial.
- People whose tissue slide images do not meet the required quality standards, or whose DeepGEM analysis was unsuccessful.
- People who have had another type of cancer within the past 5 years, with the exception of certain treated skin cancers or early-stage non-invasive cancers (confirm with trial site).
- People who have cognitive or psychological difficulties that may prevent them from understanding or accepting AI-based testing or genetic analysis.
- Women who are pregnant, breastfeeding, or who could become pregnant and are not using effective contraception.
- People with any other health condition that, in the opinion of the trial doctors, could interfere with the study or put the participant at risk.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 13802777270
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Primary endpoints
Overall Survival (OS); Targeted Therapy Utilization Rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 16 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.